Authors
-
Aminat Magomedova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Sergey Kravchenko
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Anna Misyurina
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Yana Mangasarova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Oleg Margolin
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Ekaterina Fastova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Fatima Babaeva
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Lilia Gorenkova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Madina Bagova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Ekaterina Nesterova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Ksenia Sychevskaya
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Tatyana Moiseeva
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Alla Kovrigina
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Tatyana Obukhova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Valentina Dvirnyk
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Salia Maryina
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Irina Galtseva
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Vladimir Galuzyak
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Karen Danishyan
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Irina Kostina
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Mikhail Gitis
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Andrey Sudarikov
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Elena Nikulina
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Bella Biderman
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Galina Klyasova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Gennady Galstyan
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Mikhail Spirin
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Sergey Kulikov
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Yulia Chabaeva
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Elena Zinina
Regional Clinical Hospital, Hematology Department, Surgut, Russia
-
Irina Kryuchkova
Research Institute of Fundamental Clinical Immunology, Hematology Department, Novosibirsk, Russia
-
Svetlana Sizikova
Research Institute of Fundamental Clinical Immunology, Hematology Department, Novosibirsk, Russia
-
Vera Sergeyevicheva
Research Institute of Fundamental Clinical Immunology, Hematology Department, Novosibirsk, Russia
-
Tatyana Ksenzova
Regional Clinical Hospital No. 1, Hematology Department, Tyumen, Russia
-
Ekaterina Anikina
Regional Clinical Hospital No. 1, Hematology Department, Tyumen, Russia
-
Tatyana Shelekhova
Clinic of Occupational Pathology and Hematology, Hematology Department, Saratov, Russia
-
Olga Arzhanukhina
Clinic of Occupational Pathology and Hematology, Hematology Department, Saratov, Russia
-
Kamil Kaplanov
Regional Oncological Clinic No. 1, Hematology Department, Volgograd, Russia
-
Tatyana Konstantinova
Regional Hematology Centre, Yekaterinburg, Russia
-
Olga Serdyuk
Regional Oncological Clinic. Hematology Department, Krasnodar, Russia
-
Tatyana Sychyova
Regional Clinical Hospital, Hematology Department, Astrakhan, Russia
-
Tatyana Chagorova
Regional Oncological Clinic, Hematology Department, Penza, Russia
-
Irina Nec hunayeva
City Hematology Centre, Novosibirsk, Russia
-
Lyudmila Anchukova
Regional Clinical Hospital, Hematology Department, Vologda, Russia
-
Oksana Dzarasova
Republican Clinical Hospital, Hematology Department, Vladikavkaz, Russia
-
Valery Savchenko
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
-
Elena Parovichnikova
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
Abstract
Background: NHL-BFM-90 chemotherapy is highly effective in pediatric aggressive B-cell lymphomas.
Purpose: To evaluate the efficacy and toxicity of the R-mNHL-BFM-90 and R-DAEPOCH-21 programs
in adult patients with de novo DLBCL.
Patients and methods: Inclusion criteria: newly diagnosed DLBCL (NOS), no previous chemotherapy,
2 or more signs of poor prognosis, age 18-60. The protocol included 140 patients from 13 medical
centers in Russia: R-DA-EPOCH-21 – 33; R-DAEPOCH-21+auto-HSCT - 29; R-mNHL-BFM-90 - 33;
R-mNHL-BFM-90+ auto-HSCT -35 patients.
R-DA-EPOCH-21 branch: 6 courses were performed. If CR was not achieved, 2 courses of R-DHAP
were performed ± auto-HSCT. Branch R-mNHL-BFM-90 included 6 cycles: RA-RB-RA-RB-RA-RB.
If CR was not achieved, 2 courses of R-DHAP ± auto-HSCT.